Farther Finance Advisors’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.3K Sell
133
-3
-2% -$54 ﹤0.01% 4988
2026
Q1
$2.41K Buy
136
+35
+35% +$674 ﹤0.01% 4829
2025
Q4
$1.34K Hold
101
﹤0.01% 4831
2025
Q3
$594 Buy
+101
New +$473 ﹤0.01% 4499

Other funds holding BIOA

Farther Finance Advisors's BIOA Position: Q2 2026 in Review

Farther Finance Advisors reduced its BioAge Labs (BIOA) stake by 2.2% in Q2 2026, selling an estimated $54 and leaving 133 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4988.

Farther Finance Advisors first reported a position in BIOA in Q3 2025 and has held it in 4 quarters since. 11 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Farther Finance Advisors held 133 shares of BioAge Labs worth $3.3K as of Q2 2026.
  • Farther Finance Advisors sold 3 BioAge Labs shares in Q2 2026, an estimated $54.
  • BioAge Labs made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4988 holding.
  • Farther Finance Advisors first reported a position in BioAge Labs in Q3 2025 and has held it in 4 quarters since.
  • 11 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.